Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)

This study is currently recruiting participants.
Verified December 2013 by INO Therapeutics
Sponsor:
Information provided by (Responsible Party):
INO Therapeutics
ClinicalTrials.gov Identifier:
NCT01457781
First received: October 12, 2011
Last updated: December 10, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)